Skip to main content
main-content

04.05.2018 | review

Roux-en-Y versus Billroth I following distal gastrectomy

A meta-analysis

Zeitschrift:
European Surgery
Autoren:
Haizhong Liu, Yujie Li

Summary

Aim

The aim of this study was to assess and validate the clinical efficacy of Roux-en-Y reconstruction (R-Y) when compared to Billroth I reconstruction (B-I) after distal gastrectomy (DG).

Methods

The authors identified the prospective, randomized, controlled trials comparing R‑Y with B‑I after DG for gastric cancer from January 1990 to July 2016 using PubMed, Web of Knowledge, Ovid’s database. The method of meta-analysis is performed to compare the complications and recurrences of R‑Y versus B‑I.

Result

Seven randomized controlled trials (RCTs) involving 1197 patients were included. Meta-analysis revealed that R‑Y reconstruction was associated with a significant reduction in the incidence of remnant gastritis (Odds ratios [OR] 2.58, 95%Confidence interval [CI]: 1.78, 3.74; P < 0.00001). No significant differences were observed between the groups in terms of intraoperative blood loss (Weighted mean difference [WMD] −20.97, 95%CI: −47.85, 5.92; P = 0.13), time to resumed oral intake (WMD −1.32, 95%CI: −6.39, 3.75; P = 0.61), reflux esophagitis (OR 1.71, 95%CI: 0.82, 3.57; P = 0.15), and recurrence (OR 1.10, 95%CI: 0.44, 2.71; P = 0.84). Moreover, the B‑I reconstruction method took significantly less time to perform as compared to R‑Y reconstruction (WMD −38.12, 95%CI: −50.50, −25.74; P < 0.00001) and postoperative hospital stay was shorter (WMD −2.96, 95%CI: −5.93, 0.00; P = 0.05),

Conclusion

The R‑Y reconstruction was effective in preventing gastritis, although R‑Y reconstruction after gastric resection was inferior to B‑I reconstruction in terms of taking more time to perform and a longer stay in hospital.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel
  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise